Lynch Syndrome Integrative Epidemiology and Genetics
Not yet recruiting
- Conditions
- Lynch Syndrome
- First Posted Date
- 2024-09-03
- Last Posted Date
- 2024-09-03
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 5000
- Registration Number
- NCT06582914
- Locations
- ๐บ๐ธ
University of Colorado, Aurora, Colorado, United States
๐บ๐ธUniversity of Chicago, Chicago, Illinois, United States
Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
Phase 2
Not yet recruiting
- Conditions
- Autosomal Dominant Polycystic KidneyObesity
- Interventions
- Other: PlaceboDrug: Semaglutide
- First Posted Date
- 2024-09-03
- Last Posted Date
- 2024-09-03
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 126
- Registration Number
- NCT06582875
- Locations
- ๐บ๐ธ
University of Colorado - Anschutz Medical Campus, Aurora, Colorado, United States
Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes
Recruiting
- Conditions
- Type 1 Diabetes
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 120
- Registration Number
- NCT06575842
- Locations
- ๐บ๐ธ
Barbara Davis Center, Aurora, Colorado, United States
Using Simplified Meal Boluses Versus Carbohydrate Counting in Adolescents With Hybrid Closed Loop Systems
Not Applicable
Recruiting
- Conditions
- Type 1 Diabetes
- Interventions
- Behavioral: Simple Meal BolusingBehavioral: Carbohydrate counting
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 40
- Registration Number
- NCT06575790
- Locations
- ๐บ๐ธ
Barbara Davis Center, Aurora, Colorado, United States
Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
Phase 1
Recruiting
- Conditions
- ObesityAdolescent ObesityBody-Weight TrajectoryWeight Loss TrajectoryBariatric SurgeryAnti-obesity Agents
- Interventions
- Drug: Injectable semaglutideBehavioral: Usual postoperative care
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 48
- Registration Number
- NCT06575738
- Locations
- ๐บ๐ธ
Childrens Hospital Colorado, Aurora, Colorado, United States
Cannabidiol and Cannabis Concentrate Users
Phase 2
Recruiting
- Conditions
- Cannabis Use Disorder
- Interventions
- Drug: Broad Spectrum Cannabidiol (bsCBD) 400 mgDrug: Broad Spectrum Cannabidiol (bsCBD) 200 mgDrug: Placebo
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 120
- Registration Number
- NCT06575751
- Locations
- ๐บ๐ธ
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
A Study of Cannabidiol in Young Adult Cannabis Users
Phase 2
Recruiting
- Conditions
- Cannabis Use Disorder
- Interventions
- Drug: PlaceboDrug: Broad Spectrum Cannabidiol (bsCBD) 400 mg
- First Posted Date
- 2024-08-26
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 200
- Registration Number
- NCT06569394
- Locations
- ๐บ๐ธ
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Antisense Oligonucleotide Treatment for PCARP Disease Due to Mutation in FLVCR1
Early Phase 1
- Conditions
- Posterior Column Ataxia With Retinitis Pigmentosa
- Interventions
- Drug: nL-FLVC-001
- First Posted Date
- 2024-08-22
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 1
- Registration Number
- NCT06565572
- Locations
- ๐บ๐ธ
Childrens Hospital Colorado, Aurora, Colorado, United States
CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
Phase 1
Recruiting
- Conditions
- B-cell Acute Lymphoblastic Leukemia
- Interventions
- Biological: CD19x22 CAR T
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 26
- Registration Number
- NCT06559189
- Locations
- ๐บ๐ธ
Children's Hospital Colorado, Aurora, Colorado, United States
Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations
Recruiting
- Conditions
- Cystic Fibrosis Pulmonary Exacerbation
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 50
- Registration Number
- NCT06546943
- Locations
- ๐บ๐ธ
Children's Hospital Colorado, University of Colorado Denver, Aurora, Colorado, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath